Journals / ANKEM Dergisi / 2011 / Cilt: 25 - Sayı: 2

Hidradenitis suppurativa

Hidradenitis süppürativa

Pages
121–124
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article reviews the presentation, pathogenesis and treatment of this problem.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hidradenitis suppurativa is somewhat common entity that affect especially young women.
📊
Key Findings & Data:It consists in a symptoms complex with presentations ranging from painful nodule(s), to abscesses, sinus tracts and hypertrophic scars that are located in the apocrine gland-bearing areas.
💡
Conclusion & Impact:This article reviews the presentation, pathogenesis and treatment of this problem.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hidradenitis suppurativa is somewhat common entity that affect especially young women. It consists in a symptoms complex with presentations ranging from painful nodule(s), to abscesses, sinus tracts and hypertrophic scars that are located in the apocrine gland-bearing areas. There are some risk factors, but the cause is unknown. Quality of life is severely affected even in the mild forms. Treatment is both medical and surgical and needs to be individualized to the clinical presentation. Wide-spectrum antibiotics and excisions tailored to the extent of involvement. On the other hand, some drugs such as anti-TNFa drugs and retinoids are effective, but their risk-benefit ratio is still in question. This article reviews the presentation, pathogenesis and treatment of this problem.

Özet

Hidradenitis süppürativa özellikle genç kadınlarda görülen ve belli ölçülerde yaygın olan bir hastalıktır. Apokrin ter bezi olan bölgede yerleşen bu hastalık, ağrılı bir nodülden apse, sinus oluşumu ve hipertrofik skarlara kadar değişen bir semptom kompleksinden oluşur. Klinik bulgular arasında, apokrin ter bezlerinin yerleşmiş olduğu bölgelerde ağrılı nodüller, sinus yolları ve hipertrofik skarlar vardır. Bazı risk faktörleri olmasına karşın nedeni tam olarak bilinmemektedir. Orta şiddetteki olgular bile yaşam kalitesini etkiler. Tedavi medikal ve cerrahi olup kliniğe göre bireyselleştirilmesi gerekir. Geniş spektrumlu antibiyotik ve eksizyon girişimleri tutulumunun genişliğine göre ayarlanır. Diğer yandan anti-TNFa ve retinoidler gibi bazı ilaçlar etkin olmakla beraber fayda-risk oranı açısından halen soru işaretleri vardır. Bu makalede bu sorunun sunumu yapılarak patogenezi ve tedavisi derlenmiştir.

🔖

Cite This Article

İŞGÖR, A. (2011). Hidradenitis suppurativa. ANKEM Dergisi, Cilt: 25 - Sayı: 2, 121–124. https://ajindex.com/articles/161449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Arenbergerova M, Gkalpakiotis S, Arenberger P. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy, Int J Dermatol 2010
  2. 49(12): 1445-9. http://dx.doi.org/10.1111/j.1365-4632.2010.04638.x PMid:21091684 2. Barth JH, Ng LL, Wojnarowska F, Dawber RP. Acanthosis nigricans, insulin resistance and cutaneous virilism, Br J Dermatol 1988
  3. 118(5):613-9. http://dx.doi.org/10.1111/j.1365-2133.1988.tb02561.x 3. Bong JL, Shalders K, Saihan E. Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy, Clin Exp Dermatol 2003
  4. 28(3): 241-4. http://dx.doi.org/10.1046/j.1365-2230.2003.01238.x PMid:12780702 4. Büyükaşik O, Hasdemir AO, Kahramansoy N, Cöl C, Erkol H. Surgical approach to extensive hidradenitis suppurativa, Dermatol Surg 2011
  5. 37(6):835-42. http://dx.doi.org/10.1111/j.1524-4725.2011.01961.x 5. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease, Int J Colorectal Dis 1993
  6. 8(3):117-9. http://dx.doi.org/10.1007/BF00341181 PMid:8245664 6. Delage M, Samimi M, Atlan M, Machet L, Lorette G, Maruani A. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers, Acta Derm Venereol 2011
  7. 91(2):169-71. PMid:21384087 7. Finley EM, Ratz JL. Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing, J Am Acad Dermatol 1996
  8. 34(3):465-9. http://dx.doi.org/10.1016/S0190-9622(96)90441-7 8. Fröhlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa-still valid today? Stranlenther Onkol 2000
  9. 176(6):286-9. PMid:10897256 9. Gupta AK, Ellis CN, Nickoloff BJ et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis, Arch Dermatol 1990
  10. 126(3):339-50. http://dx.doi.org/10.1001/archderm.126.3.339 PMid:2178558 10. Jansen I, Altmeyer P, Piewig G. Acne inversa (alias hidradenitis suppurativa), J Eur Acad Dermatol Venereol 2001
  11. 15(6):532-40. http://dx.doi.org/10.1046/j.1468-3083.2001.00303.x PMid:11843212 11. Jansen T, Plewig G. Acne inverse, Int J Dermatol 1998
  12. 37(2):96-100. http://dx.doi.org/10.1046/j.1365-4362.1998.00414.x 12. Jemec GB. The symptomatology of hidradenitis suppurativa in women, Br J Dermatol 1988
  13. 119(3): 345-50. http://dx.doi.org/10.1111/j.1365-2133.1988.tb03227.x PMid:3179207 13. Morgan WP, Leices